Deprecated: Creation of dynamic property PL_VBP_License::$version is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/license-page.php on line 92

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the listeo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170

Deprecated: Creation of dynamic property Vidbg_WPBakery::$vc_row_atts is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/inc/classes/vidbg_wpbakery.php on line 49
Learn - Page 5 of 95 - HealingMaps

Ketamine Raised Morning Cortisol in a New Trial. Here Is What That Might Mean

A randomized trial found higher morning cortisol 24 hours after ketamine. Bigger rises tracked with less suicidal thinking, though more data needed.

Read More

Cluster Headaches Have New Trial Data. Ketamine Clinics Should Be Paying Attention

Two 2024 randomized trials cut cluster headache attacks with pulse dose psilocybin. Where ketamine sits, why these patients overlap with yours, and the access gap.

Read More

Ketamine Patients and GLP-1 Patients Are Often the Same People

47 percent of peptide clinics now offer a GLP-1. Depression, drinking and metabolic disease cluster in the same patients.

Read More

Psychedelic Trials Are Going Intravenous. Ketamine Clinics Already Have That Room

A new trial of intravenous psilocin points to where psychedelic delivery is heading. Ketamine clinics already have the infusion rooms and titration skills it needs.

Read More

Three Psychedelic Companies Analysts Say Could Be Acquired Next

The Deal That Changed the Temperature Eli Lilly agreed in July to pay up to $3.8 billion for AtaiBeckley. That number reset expectations across psychedelic medicine. Analysts now openly discuss which company gets bought next. For clinic owners, the question matters more than it might appear. The companies being courted are building the treatments your […]

Read More

Five Months After Lilly’s B12 Warning, 1 in 7 Tirzepatide Clinics Still Advertises the Combination

Eli Lilly warned in March that compounded tirzepatide with B12 forms an uncharacterized impurity. We checked 800 clinic websites to see how many still advertise the combination.

Read More

Why Some Psychedelic Sessions Turn Frightening. A New Brain Study Offers a Clue

Most people who take a psychedelic under clinical supervision come through the session well. Some do not. A 2026 Stanford study in the Proceedings of the National Academy of Sciences offers a partial explanation for that difference. The clue sits in an unexpected place, namely the direction brain signals travel. Do you work in the […]

Read More

New Research Links Your Immune System to Depression Relief

Researchers found that these therapies change how the immune system talks to the brain. The work appeared in the journal Molecular Psychiatry.

Read More

The FTC Just Sued Hims & Hers Over Tracking Pixels. Your Clinic Probably Runs Them Too

The FTC, Utah and California sued Hims & Hers over health data sharing, billing and cancellations. The practices named are common at cash pay clinics.

Read More

Nine of 12 Veterans Reached PTSD Remission After Psilocybin Therapy in Small Study

A small clinical trial found striking improvements among veterans with severe post traumatic stress disorder that had resisted standard care. Nine of 12 participants no longer met PTSD criteria one month after psilocybin assisted therapy. The result offers an important signal, but the study cannot prove that the treatment caused the improvement. Looking for treatment? Find Spravato clinics […]

Read More